SGX-523 ≥98%|CAS:1022150-57-7|1 mg|5 mg|

SGX523|SGX-523 is an inhibitor of MET that exhibits anticancer chemotherapeutic activity. SGX-523 inhibits growth of cells and tumors in models of non-small cell lung cancer (NSCLC). SGX-523 also improves the efficacy of co-administered treatments, further suppressing growth in animal models of lung cancer, breast cancer, and pancreatic cancer.|C18H13N7S|359.41||-20°C|